Success Metrics

Clinical Success Rate
84.2%

Based on 234 completed trials

Completion Rate
84%(234/278)
Active Trials
39(10%)
Results Posted
63%(147 trials)
Terminated
44(11%)

Phase Distribution

Ph not_applicable
55
14%
Ph phase_3
47
12%
Ph early_phase_1
6
2%
Ph phase_1
60
16%
Ph phase_2
78
20%
Ph phase_4
128
33%

Phase Distribution

66

Early Stage

78

Mid Stage

175

Late Stage

Phase Distribution374 total trials
Early Phase 1First-in-human
6(1.6%)
Phase 1Safety & dosage
60(16.0%)
Phase 2Efficacy & side effects
78(20.9%)
Phase 3Large-scale testing
47(12.6%)
Phase 4Post-market surveillance
128(34.2%)
N/ANon-phased studies
55(14.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.0%

234 of 300 finished

Non-Completion Rate

22.0%

66 ended early

Currently Active

39

trials recruiting

Total Trials

383

all time

Status Distribution
Active(51)
Completed(234)
Terminated(66)
Other(32)

Detailed Status

Completed234
Terminated44
unknown30
Recruiting29
Withdrawn22
Not yet recruiting10

Development Timeline

Analytics

Development Status

Total Trials
383
Active
39
Success Rate
84.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (1.6%)
Phase 160 (16.0%)
Phase 278 (20.9%)
Phase 347 (12.6%)
Phase 4128 (34.2%)
N/A55 (14.7%)

Trials by Status

recruiting298%
unknown308%
suspended21%
enrolling_by_invitation21%
completed23461%
not_yet_recruiting103%
terminated4411%
active_not_recruiting103%
withdrawn226%

Recent Activity

Clinical Trials (383)

Showing 20 of 383 trialsScroll for more
NCT07634393Phase 4

Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment

Not Yet Recruiting
NCT02832687Phase 4

Multi-dose Acetaminophen for Patients Undergoing General Anesthesia

Terminated
NCT07570173Phase 2

A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

Recruiting
NCT03907176Phase 3

Study of Post-Herniorrhaphy Non-opioid MMA Regimens

Completed
NCT07567924Phase 4

Comparison Between Pregabalin and Acetaminophen for the Treatment of Post-Mastectomy Pain Syndrome

Completed
NCT06434233Phase 4

Opioid Use After Laparoscopic Salpingectomy

Recruiting
NCT05076110Phase 4

Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

Completed
NCT05597878Phase 2

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Terminated
NCT05285813Phase 2

A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure

Terminated
NCT06186622Phase 1

A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants

Completed
NCT03805932Phase 1

Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia

Active Not Recruiting
NCT06326983Not Applicable

Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery

Completed
NCT06009926Phase 2

Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters

Active Not Recruiting
NCT04165096Phase 2

KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C)

Completed
NCT05878015Phase 4

A Study of Intravenous Acetaminophen for Small Bowel Obstruction

Enrolling By Invitation
NCT04221477Phase 3

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis

Active Not Recruiting
NCT07571252Phase 4

Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic Surgery

Not Yet Recruiting
NCT06043323Phase 2

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

Recruiting
NCT06762600Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects

Completed
NCT07525791Phase 1

A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
383